Evidence map›Paper›PMID 40167914›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Application of Isotope Dilution Gas Chromatography-Mass Spectrometry Using Selected Ion-Monitoring to Evaluate Nonenzymatic Protein Damage in Cerebrospinal Fluid.

Natalia Mota-Martorell, Mariona Jové Font, Anna Fernàndez-Bernal, Idoia Company-Marín, Alba Juanes-Casado, Reinald Pamplona

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Natalia Mota-MartorellDepartment of Experimental Medicine, Lleida Biomedical Research Institute, University of Lleida, Lleida, Spain.
Mariona Jové FontDepartment of Experimental Medicine, Lleida Biomedical Research Institute, University of Lleida, Lleida, Spain.
Anna Fernàndez-BernalDepartment of Experimental Medicine, Lleida Biomedical Research Institute, University of Lleida, Lleida, Spain.
Idoia Company-MarínDepartment of Experimental Medicine, Lleida Biomedical Research Institute, University of Lleida, Lleida, Spain.
Alba Juanes-CasadoDepartment of Experimental Medicine, Lleida Biomedical Research Institute, University of Lleida, Lleida, Spain.
Reinald PamplonaDepartment of Experimental Medicine, Lleida Biomedical Research Institute, University of Lleida, Lleida, Spain. reinald.pamplona@udl.cat.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mass spectrometry (MS)-based approach for the detection and quantification of nonenzymatic posttranslational modifications (PTMs) is a powerful technology to measure the dynamics of proteome damage with high throughput and deep coverage. Here, we describe a gas chromatography-mass spectrometry with a selected ion-monitoring mode (SIM-GC/MS) method for protein damage profiling of biological and clinical samples. This approach can be carried out on materials ranging from isolated proteins to tissue/biofluid samples. In particular, the SIM-GC/MS method is applied to detect and quantify diverse protein damage markers in the human cerebrospinal fluid (CSF) proteome. The protocol includes protein extraction, digestion, derivatization, PTMs detection and quantification by GC/MS, followed by computational data processing. Different protein damage markers of oxidation, glycoxidation, lipoxidation and succination can be confidently detected and quantified simultaneously. This protocol provides a general protein nonenzymatic modification measurement tool, enabling the dissection of protein and proteome modifications in a particular biofluid, the CSF.

Indexed as

Cerebrospinal Fluid ProteinsGas Chromatography-Mass SpectrometryProteomeProteomicsBiomarkersHumansProtein Processing, Post-TranslationalBiomarkersCerebrospinal Fluid ProteinsProteomeCerebrospinal fluidGas chromatography-mass spectrometryGlycoxidationLipoxidationOxidationProteomeSelected ion-monitoringSuccinationTrifluoroacetic acid methyl esters

Identifiers

PMID40167914

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.